(JAMA and Archives Journals) An analysis of comparative effectiveness studies finds that few compare medications with nonpharmacologic interventions, and few examine safety or cost-effectiveness, according to a study in the March 10 issue of JAMA.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Chemistry
- LSUHSC research identifies new prostate cancer drug target
- Padded headgear, boxing gloves may offer some protection for fighters
- Study evaluates antibiotic option for treating bladder infection in women
- Parkinson's disease: Study of live human neurons reveals the disease's genetic origins
- MIT: New tool for analyzing solar-cell materials